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Summary The radioprotector 2-[(aminopropyl)amino] ethanethiol (WR1065) was investigated with respect to
its ability to affect radiation-induced DNA damage and repair in V79 cells. Studies were performed to
evaluate the protector under conditions in which it is known to be effective in reducing the cytotoxic and
mutagenic effects of y-irradiation. At a concentration of 4mM, WR1065 protected against the formation of
single strand breaks (SSB), as determined by the method of alkaline elution, when it was present during
irradiation. The protector appeared, however, to inhibit the subsequent postirradiation repair or rejoining of
SSB. While repair was complete within 24h, the protector reduced the rate of repair by a factor of 3. This
inhibitory effect on the rate of repair did not correlate with either measured differences in cell survival or
mutagenesis. The radioprotector was also investigated with respect to its ability to affect cell cycle
progression. WR1065 present in the growth medium inhibited the progression of cells through S-phase, and
cell-doubling time following a 3 h exposure to the protector was increased from 11 to 18h. These data are
consistent with the well characterized property of thiols to inhibit DNA polymerase activity. It was concluded
that, while the presence of WR1065 during irradiation reduced SSB-DNA damage, its effect on the
subsequent rejoining of these breaks could not be correlated with its observed effect on protecting against
radiation-induced mutagenesis. It may be that the inhibition of cell-cycle progression by the protector allowed
more time to enhance the fidelity of repair as measured by the protector's ability to protect against radiation-
induced mutagenesis.
There is currently considerable interest in the
application of aminothiol compounds such as N-(2-
mercaptoethyl)-1, 3-diaminopropane (WR2721) for
use in clinical radio- and chemotherapy. This
interest stems from observations that these agents
can protect preferentially normal as compared to
neoplastic tissues against both acute and late
arising radiation injuries (Yuhas et al., 1980;
Phillips, 1980). Recently, it has been reported that
WR2721 possesses anticarcinogenic properties as
well (Milas et al., 1984). Rodents administered
WR2721 i.p. at a dose of 400mgkg- 30min before
irradiation developed fewer tumors in the irradiated
field when compared to matched controls not given
the radioprotector.
These observations prompted a series of studies
in our laboratory to further characterize the
possible modulating effect(s) of radioprotectors on
processes involved in mutagenesis, transformation,
and carcinogenesis. In subsequent investigations, N-
(2-mercaptoethyl)-1,3-diaminopropane (WR1065),
the corresponding free thiol of the well charac-
terized radioprotector WR2721 (Purdie, 1979), was
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found to be effective in protecting against the
mutagenic effects induced by both ionizing
radiation (Grdina et al., 1985a) and
chemotherapeutic agents such as cis-diammine-
dichloroplatinum (cis-DDP) (Nagy et al., 1986) and
bleomycin (BLM) and nitrogen mustard (HN2)
(Nagy & Grdina, 1986). These studies were
performed using a V79 Chinese hamster lung
fibroblast system and a hypoxanthine-guanine
phosphoribosyl transferase (HGPRT) mutational
assay. With respect to radiation, this effect was
apparent even if the radioprotector was added up
to 3h following irradiation (Grdina et al., 1985a).
WR1065 has also been observed to be effective in
protecting against radiation-induced transformation
in IOT1/2 cells (Hill et al., 1986). Finally, WR2721
protected against the incidence of radiation-induced
altered hepatocyte foci in rats exposed within one
day of birth (Grdina et al., 1985b). These lesions are
known to be early indicators of hepatic neoplasia in
this system (Peraino et al., 1984).
Because of the protective effect exhibited by these
compounds in a variety of test biological systems, it
was of interest to us to further investigate these
compounds with respect to their ability to modulate
radiation-induced DNA damage and repair
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especially at biologically relevant doses of radiation
known to be effective in inducing HGPRT
mutations. In addition, since it has been reported
that thiol-containing compounds such as cysteamine
can induce single-strand-break (SSB) damage in
DNA as well as inhibit its repair (Sawada &
Okada, 1970), we have focused this investigation
towards characterizing the role of the radio-
protector WR1065 with respect to (a) the induction
of SSB in DNA of unirradiated and irradiated cells,
(b) the rejoining or repair of that damage, and (c)
the modulation of cell-cycle kinetics. Each of these
parameters have been studied using V79 cells under
conditions known to be effective in protecting
against mutagenesis and/or cell killing (Grdina et
al., 1985a).
Materials and methods
Cell system
V79-B310H Chinese hamster cells were maintained
as stock cultures in a minimal essential medium
(Gibco) with 10% foetal calf serum (Biologos) in a
humidified atmosphere containing 5% CO2 and
95% air at 37°C. A complete description of culture
conditions are described elsewhere (Suzuki et al.,
1981).
Irradiation
Exponentially growing cells were harvested and
irradiated at ice bath temperatures using 60Co y-
rays from a Gamma beam 650 irradiator (Atomic
Energy of Canada) at a dose rate of 0.5Gymin-m
(Han et al., 1980). With respect to dose-response
studies, irradiated cells were immediately diluted
into ice-cold Solution A (8.0gNaCl, 0.4gKCl, 1.0g
glucose, 0.35gNaHCO3, per litre) containing 5mM
EDTA to insure an inhibition of DNA repair
(Meyn & Jenkins, 1983). DNA repair studies were
performed using cells irradiated with 10Gy.
Following irradiation, cells were added to pre-
warmed culture medium and were incubated at
37°C for the desired time.
Radioprotector
The radioprotector WR1065 was always made up
as a 1 M stock solution in PBS (Dulbecco's PBS;
Gibco) on the day of its use. It was routinely added
to selected cell suspensions to give rise to a final
concentration of 4mM. This concentration was
observed to afford maximum protection to V79
cells with respect to radiation or drug-induced cell
killing and mutagenesis without evidence of any
associated protector-induced cytotoxicity (Grdina et
al., 1985a; Nagy et al., 1986). Each of the studies
described was performed using the same batch of
WR1065 (Chemical #BK 71365) obtained from
the Division of Experimental Therapeutics, Walter
Reed Army Medical Center, Washington, D.C.
20307, USA.
Alkaline elution
The alkaline elution technique has been described
in detail elsewhere (Kohn, 1979; Meyn & Jenkins,
1983). Briefly, 6 to 8 million cells were impinged
onto 47mm diameter (0.8,im pore size)
polycarbonate filters (Nuclepore Corp., Pleasanton,
CA, USA). Cells were washed twice with cold
Solution A and were then lysed with 10ml of 2M
NaCl-0.04M EDTA-0.2% Sarkosyl (pH 10.3). The
lysis solution was allowed to flow through the filter
by gravity. Following this, the filter was rinsed with
IOml of 0.02M EDTA (pH 10.3) and eluted in the
dark with 0.1 M tetrapropylammonium hydroxide
and 0.02M EDTA (pH 12.1). Routinely, a flow rate
of 0.04mlmin - I was used and fractions were
collected every 90min for 15h. The DNA
remaining on the filter was removed by vortexing in
5ml of the eluting solution.
Fluorometric analysis ofDNA
The analysis of DNA in the alkaline elution studies
was performed using a microfluorometric technique
described in detail elsewhere (Cesarone et al., 1979).
Briefly, DNA determinations were made using
Hoechst 33258 dye. One ml aliquots of each elution
fraction along with the filter and a wash of the
filter holder were removed and placed into glass
test tubes. Each sample was then neutralized with
0.4ml of 0.2M KH2PO4 and 0.6ml of water was
added to bring up the volume to 2ml. Hoechst dye,
1.5 x 10-6M in 0.9% citrated NaCl solution, was
added in a one ml volume to each sample tube, and
the resulting solutions were vortexed. Fluorescence
was then measured using a model LS-5 Perkin
Elmer (Oak Brook, IL, USA) fluorescence spectro-
photometer. The excitation wave length was set at
360nm while the emission wave length was measured
at 460nm (Meyn & Jenkins, 1983; Nagy & Grdina,
1986). This method has been demonstrated to
accurately represent the kinetics of DNA elution
when compared to techniques using radioactive
methods (Meyn & Jenkins, 1983).
Calculation ofstrand scissionfactors
The designation strand scission factor (SSF) refers
to a relative value determined as a result of the
comparison of associated DNA elution curves. This
value is used to characterize the relative number of
DNA-strand breaks present. Specifically, SSF was
determined from the relationship: SSF=Ilog((fx)/EFFECT OF WR1065 ON DNA DAMAGE AND REPAIR 935
(fo))1, where fo and fx are, respectively, the
proportion of DNA retained on the filter after an
eluted volume of 17.5ml for the unirradiated
control and the corresponding treated sample
(Murray et al., 1984).
Flow cytometry analysis
The determination of the DNA content of control
and treated V79 cells as well as the evaluation of
the effects of WR1065 on cell-cycle progression was
made using the technique of flow cytometry
(FCM). Cells was stained with DAPI (4', 6-
diamidino-2-phenylindole) (Russel et al., 1975) in a
0.1% citrate solution according to a method
described elsewhere (Gohde et al., 1978; Gohde et
al., 1979). FCM patterns were obtained using a
'PARTEC' PAS-II (Particle Analyzing System)
(Partec AG, Basel, Switzerland) and were analyzed
using a computer program obtained from
TECHNO SYSTEM-GMBH (Darmstadt, West
Germany). The coefficient of variation (cv) of the
Gl peak obtained using unperturbed cell samples
routinely ranged from 1.5 to 2.5%.
Experimental design
As described earlier, the radioprotector WR1065
was very effective in protecting against radiation-
induced cell killing and mutagenesis. To determine
the effectiveness of this protector on radiation-
induced DNA damage and/or repair, experimental
conditions were duplicated as much as possible to
reflect those used in our original study (Grdina et
al., 1985a). Briefly, cells were treated under the
following conditions: (A) The radioprotector was
added to cells 30min prior to irradiation. Cells
were incubated at 37°C but were irradiated at ice
bath temperatures. Immediately after radiation
exposures, the cells were washed free of the
protector and either alkaline elution was performed
(e.g., dose response) or cells were incubated for
various periods of time at 37°C to assess the
kinetics of DNA repair. Parallel studies were
performed on cells not exposed to WR1065. (B)
The radioprotector was added immediately
following irradiation and was allowed to remain for
up to 180min to assess its effects on DNA repair.
Again, parallel experiments were performed on cells
not exposed to the radioprotector. (C) Unirradiated
cells were exposed to WR1065 for up to 180min.
During that time, aliquots of cells were removed
and their DNA distributions were determined using
FCM analysis. Following 180min of incubation at
37°C in the presence of the protector, the remaining
cells were washed free of the compound and their
progression was monitored for an additional
180min.
Results
To determine whether the radioprotector WR1065
can induce SSB in DNA of exposed V79 cells, cells
were treated with 4mM for times ranging from
30min to 180min. As shown in Figure 1, under
these conditions no appreciable damage could be
demonstrated as a result of exposure of cells to this
compound. The effect of WR1065 on the formation
of radiation-induced SSB is described in Figure 2.
These are representative data from a single
experiment, and each experiment was repeated at
least three times. The radioprotector was added
30min prior to irradiation and the cells were
irradiated in its presence. Compared to unprotected
cells, cells irradiated in the presence of WR1065
appeared to have fewer SSB.
Because of the antimutagenic activity exhibited
by WR1065 (Grdina et al., 1985a; Nagy et al.,
1986; Nagy & Grdina, 1986), it was of interest to
determine the effects of this agent on the kinetics of
DNA repair following irradiation. Presented in
Figure 3 are DNA elution profiles describing the
rejoining of SSB as a function of time for
unprotected cells irradiated with 1OGy and then
incubated at 37°C. Following 90min of incubation,
the elution patterns of unirradiated control and
irradiated cells were indistinguishable. In contrast,
irradiated cells allowed to repair in the presence of
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Figure 1 Alkaline elution profiles depicting the
elution kinetics of DNA from V79 cells exposed to
4mM WR1065 for various periods of time.936 D.J. GRDINA & B. NAGY
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Figure 2 Representative alkaline elution profiles
depicting the elution kinetics of DNA from V79 cells
exposed to various doses of y-rays in the presence or
absence of 4mM WRI065 (these and all subsequent
elution experiments were repeated 3 times).
4mM WR1065 immediately following irradiation, a
condition known to protect against mutagenesis at
the HGPRT locus (Grdina et al., 1985a), exhibited
a much slower kinetics of repair (see Figure 4).
Even after 180min, the elution curves of irradiated
cells did not return to control levels. If cells were
removed from the radioprotector and allowed to
repair, complete rejoining of breaks was observed
within 24h of incubation (data not shown).
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Figure 3 Representative alkaline elution profiles
depicting the elution kinetics of DNA from V79 cells
exposed to 1OGy and allowed to repair at 37°C for
various periods of time following irradiation (see
Figure 2).
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Figure 4 Alkaline elution profiles depicting the
elution kinetics of DNA from V79 cells exposed to
1OGy and then allowed to repair in the presence of
4mM WRl065 at 37°C for various periods of time
following irradiation (see Figure 2).
Data describing the relative rates of repair of
irradiated cells incubated in the presence or absence
of the radioprotector have been summarized from a
series of alkaline elution experiments and are
presented in Figure 5 for comparison. A relative
SSF of 1 indicates maximum SSB damage, e.g.,
100% SSBs. A reduction in this value is a measure
of the relative repair or rejoining of these lesions.
The curves were analyzed using a modification of a
1/2 life of decay algorithm developed by Tyler and
Dipert (personal communication, Argonne National
Laboratory) using an IBM-30333 computer. The
1/2 life of decay of SSB over a 180min period (e.g.,
the repair of SSB) was calculated to be 88+19min
and 27+4min for cells incubated in the presence or
absence of WR1065, respectively, giving rise to a
reduction in the rate of rejoining of SSB induced by
the protector of about a factor of 3. Similarly, if
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Figure 5 Relative rates of SSB rejoining in the
presence or absence of WR1065 (4mM) following
10Gy. A relative SSF of 1 represents 100% of single
strand breaks (SSB) remaining following irradiation
(see Figures 3 and 4).
cells were exposed to the protector 30min prior to
irradiation as well as during the postradiation
repair process, the rate and the magnitude of repair
was inhibited to the same degree (see Figure 6). The
addition of the radioprotector immediately after
irradiation for an exposure time of only 30min was
sufficient to inhibit DNA rejoining processes to a
similar extent (see Figure 7).
These observations prompted a further investi-
gation into the effects of this protector compound
on cell cycle kinetics. Presented in Figure 8 are
FCM histograms describing the DNA distributions
of V79 cells exposed to 4mM of WR1065 for
varying times (e.g., 0 to 3 h, the 'A' panels), as well
as histograms describing the DNA distribution of
cells as a function of time following the removal of
protector containing medium (e.g., the 'B' panels).
The corresponding percentages of cells in G1, S,
and G2 +M presented in Figure 8 as a function of
these conditions are presented in Figure 9.
Discussion
The experiments described in this manuscript
concerning the use of the radioprotector WR1065
were designed to mimic those conditions which are
known to be effective in reducing the cytotoxic
and/or mutagenic effects of radiation (Grdina et al.,
1985a). In particular, when this agent is present
during irradiation at doses equal to or less than
10Gy, cell survival is increased by a factor of 1.9
Relative rates of DNA repair
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Figure 6 Relative rates of SSB rejoining in the
absence of WR1065 or under conditions in which the
protector was added 30min prior to radiation and
allowed to remain during as well as for selected
periods of time following irradiation. Relative SSF
were obtained from elution profiles similar to those
presented in Figures 3 and 4.
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Figure 7 Relative rate of DNA repair for cells
exposed to 10Gy and then immediately exposed to
WR1065 for 30min following irradiation.
and the induction of HGPRT mutants is reduced
by 65% (Grdina et al., 1985a). If the protector is
added immediately after irradiation or even up to
3 h following irradiation for an exposure time of
3h, cell survival is not affected, but the induction
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Figure 8 Flow cytometric profiles describing the DNA contents of V79 cells exposed to the radioprotector
WR1065: C-panel represents untreated control cells; A-panels represent cells harvested from plates containing
4mM WR1065, the time of exposure to the protector is listed in each panel; B-panels represent cells exposed
to 4mM WR1065 for 3h, then washed free of the protector, and then incubated in protector-free medium for
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Figure 9 The percentages of cells in GI, S, and
G2+ M comprising the FCM profiles presented in
Figure 8 are presented for comparison.
of mutants is reduced by 45% as compared to the
induction of mutants in nonprotected cells (Grdina
et al., 1985a). This reduction in the number of
HGPRT mutants, however, has been shown not to
be related to a selective toxicity of the protector to
the HGPRT mutants (Nagy et al., 1986).
These data suggest that WR1065 is differentially
affecting two general classes of lesions, e.g., those
leading to cell death and those involved in
mutagenesis. The failure to affect cell survival if
administered after radiation suggests that
potentially lethal lesions can exist which once
formed cannot be significantly altered through the
action of the radioprotector. In contrast, lesions
and/or repair processes leading to the expression of
HGPRT mutations can be affected even under
postirradiation conditions. HGPRT mutations
induced by ionizing radiation are believed to be
primarily due to gross genetic damage (e.g.,
deletions and rearrangements) rather than by point
mutations (Cox & Masson, 1978; Thacker, 1986).
Thus, the role of protectors in affecting base
damage, which presumably could lead to the
induction of point mutations, is unclear. One might
conclude, however, that WR1065 does in some
manner affect those processes involved in the
radiation-induced destabilization of the genome
which, in the case of HGPRT mutants, ultimately
leads to sub-lethal and mutagenic events.
While the role of SSB in these processes is at
present unclear, it was initially thought that the
induction of these lesions by irradiation might in
some way facilitate the mutagenic process. To test
this possibility, we assessed the effect of WR1065
on SSB formation using the method of alkaline
elution. Because certain thiol-containing com-
pounds have been observed to induce SSB in DNA
(Sawada & Okada, 1970), it was important to
determine if such damage could be formed by
exposure of cells to the protector alone. As shown
in Figure 1, no such damage was detected under
the conditions tested.
The observation that fewer SSB are formed in
cells exposed to WR1065 during irradiation as
compared to corresponding controls is consistent
with our findings that this condition leads to
increased survival of cells and reduced mutation-
induction frequencies (Grdina et al., 1985a). That
the presence of the radioprotector inhibited the rate
and the magnitude of SSB repair is also consistent
with earlier reports (La Salle & Billen, 1964;
Sawada & Okada, 1970). In addition, it has been
reported using bacteria that radioprotectors such as
cysteamine can lead to a reduction in the rejoining
of SSB through the inhibition of DNA polymerase
1-directed repair synthesis (Billen, 1983). While the
exact mechanism of this inhibition is at present
unclear, it is known that most thiols of low
molecular weight possess a high affinity for selected
metal ions (Jellum et al., 1973). Since many
polymerases require metal cofactors for activity
(Kornberg, 1980), it may be that the metal-
chelating property of these thiols is a prime factor
in their ability to inhibit DNA polymerase activity.
This inhibitory property is clearly evident in the
case of WR1065. Not only is this compound
effective in impairing the rejoining of SSB (see
Figures 4-7), but it is also efficient in perturbing
cell-cycle kinetics (see Figures 8 and 9). As a result
of exposure to this compound, cells appear, as a
function of time, to be progressing from the Gl
compartment and accumulating in S phase. This
effect is reversible upon removal of the drug, and
under the conditions described, does not lead to cell
death (Grdina et al., 1985a; Nagy et al., 1986). A
3h exposure of cells to WR1065 does, however,
affect cell growth in that the doubling time is
increased from about 11 to 18 h (data not
presented).
As described earlier, the rejoining of SSB in the
absence of the radioprotector appears to be
complete by 90min (see Figure 3). However, it has
been observed that WR1065 can protect against the
formation of radiation-induced HGPRT mutants
even if it is added up to 3 h following irradiation, a
time at which the rejoining process appears to be
completed (Grdina et al., 1985). It would appear,
therefore, that the rate of rejoining of SSB is not a
major determinant in the ultimate development of
HGPRT mutants. Clearly, it is the enhancement in940 D.J. GRDINA & B. NAGY
the fidelity of the rejoining process which would be
important.
The effect of the protector on cell-cycle
progression delay is significant. It is known that cell
division is an important step in the fixation of
mutational and/or transformational events (Chu &
Malling, 1968; Farber, 1984). A radioprotector,
such as WR1065, which is capable of prolonging
the time required for cell division without the
expression of a concomitant cytotoxic effect would
be expected to be an effective antimutagen or
anticarcinogen. In this manner, more time would be
available for repair. This, in turn, could lead to an
enhanced fidelity of repair which would be reflected
in a reduction in mutation frequency (Grdina et al.,
1985a).
Finally, thiols such as WR1065 are also known
to be effective free radical scavengers (Yuhas et al.,
1980; Phollips, 1980). Since radiation produces free
radicals, and free radicals are implicated in the
processes of cell killing, mutagenesis, trans-
formation, and carcinogenesis (Greenstock, 1981;
Slaga et al., 1981), it is reasonable to expect that
agents possessing this capability should play a
significant role in modulating these processes. This
protective effect would, presumably, extend to free
radicals formed during metabolic processes
subsequent to irradiation which might interact to
either augment existing damage or perturb the
repair of that damage, thus leading to enhanced
mutation rates. Evidence for this possibility has
been presented using the free radical scavenger
superoxide dismutase (SOD) (Borek & Troll, 1983).
SOD was reported to be effective in reducing the
frequency of radiation-induced transformations
following prolonged postirradiation exposure.
The radioprotector WR2721 and its free thiol
WR1065 have been extensively studied because of
their potential for increasing the therapeutic gain of
radiotherapy as a consequence of their ability in
selected cases to protect differentially normal as
compared to neoplastic tissues. Clearly, potential
mechanisms by which these agents express their
protective effect are numerous. However, emphasis
should not be directed towards only investigating
their ability to reduce initial radiation damage but,
rather, consideration should also be given to better
understanding their ability to affect postirradiation
processes (e.g., affects on DNA repair synthesis and
cell-cyle progression) which are involved in
mutagenesis, transformation, and carcinogenesis.
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